1D 1W 1M 3M 6M 1Y 3Y 5Y 10Y
| Index Name | Current Value | Change | % Change |
|---|---|---|---|
| NFTMIDSMLHEALTH | 47641.1 | 78.2 | 0.2% |
| Company Name | Current Value (₹) | Change(₹) | Price(%) |
|---|---|---|---|
| Dr. Lal Pathlab... | 1649.8 | 83.1 | 5.3% |
| Sai Life Scienc... | 1115.6 | 26.5 | 2.4% |
| Mankind Pharma ... | 2430.8 | 55.4 | 2.3% |
| Neuland Laborat... | 17666.0 | 365.5 | 2.1% |
| Laurus Labs Ltd... | 1228.3 | 21.8 | 1.8% |
| Lupin Ltd. | 2379.5 | -80.3 | -3.3% |
| Syngene Interna... | 458.1 | -11.3 | -2.4% |
| Narayana Hruday... | 1820.3 | -41.8 | -2.2% |
| Piramal Pharma ... | 179.9 | -4.0 | -2.2% |
| Wockhardt Ltd. | 1606.5 | -30.3 | -1.8% |
₹ |
1D 1W 1M 3M 6M 1Y 3Y 5Y 10Y
| Sl # | Index Name | Current Value | Change | % Change |
|---|---|---|---|---|
| 1 | Lupin Ltd. | 2379.5 | -80.3 | -3.3% |
| 2 | Abbott India Ltd. | 26700.0 | 7.8 | 0.0% |
| 3 | Glaxosmithkline Pharmaceuticals Ltd. | 2476.9 | -2.0 | -0.1% |
| 4 | Pfizer Ltd. | 4818.8 | 69.2 | 1.5% |
| 5 | JB Chemicals & Pharmaceuticals Ltd. | 2149.8 | 8.5 | 0.4% |
| 6 | Ipca Laboratories Ltd. | 1552.6 | -5.3 | -0.3% |
| 7 | Neuland Laboratories Ltd. | 17666.0 | 365.5 | 2.1% |
| 8 | Aurobindo Pharma Ltd. | 1487.3 | 8.8 | 0.6% |
| 9 | Natco Pharma Ltd. | 1174.7 | 20.5 | 1.8% |
| 10 | Poly Medicure Ltd. | 1652.1 | -27.4 | -1.6% |
| 11 | Glenmark Pharmaceuticals Ltd. | 2366.4 | -4.7 | -0.2% |
| 12 | Wockhardt Ltd. | 1606.5 | -30.3 | -1.8% |
| 13 | Ajanta Pharma Ltd. | 3035.0 | -45.2 | -1.5% |
| 14 | Granules India Ltd. | 753.0 | 9.6 | 1.3% |
| 15 | Biocon Ltd. | 380.4 | -2.2 | -0.6% |
| 16 | Fortis Healthcare Ltd. | 952.4 | 4.9 | 0.5% |
| 17 | Sai Life Sciences Ltd. | 1115.6 | 26.5 | 2.4% |
| 18 | Syngene International Ltd. | 458.1 | -11.3 | -2.4% |
| 19 | Mankind Pharma Ltd. | 2430.8 | 55.4 | 2.3% |
| 20 | Alkem Laboratories Ltd. | 5585.5 | -5.4 | -0.1% |
| 21 | Narayana Hrudayalaya Ltd. | 1820.3 | -41.8 | -2.2% |
| 22 | Dr. Lal Pathlabs Ltd. | 1649.8 | 83.1 | 5.3% |
| 23 | Aster DM Healthcare Ltd. | 742.4 | 4.2 | 0.6% |
| 24 | Krishna Institute of Medical Sciences Ltd | 717.6 | 10.1 | 1.4% |
| 25 | Gland Pharma Ltd. | 1904.4 | 33.2 | 1.8% |
| 26 | Laurus Labs Ltd. | 1228.3 | 21.8 | 1.8% |
| 27 | Global Health Ltd. | 1200.6 | -13.8 | -1.1% |
| 28 | Cohance Lifesciences Ltd. | 488.2 | 3.3 | 0.7% |
| 29 | Piramal Pharma Ltd. | 179.9 | -4.0 | -2.2% |
| 30 | Onesource Specialty Pharma Ltd. | 1835.2 | 18.7 | 1.0% |
| # | Company | CMP | M Cap | 52W High | 52W Low | PE | PB | ROCE Last Yr | ROE Last Yr | PAT TTM | Div Yield |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lupin Ltd. | 2379.5 | 108795 | 2492 | 1838.6 | 32.9 | 6.3 | 22 | 21.1 | 5355 | 0.6 |
| 2 | Mankind Pharma Ltd. | 2430.8 | 100350 | 2726.8 | 1909.9 | 50 | 7 | 18.3 | 17 | 1797 | 0 |
| 3 | Aurobindo Pharma Ltd. | 1487.3 | 86383 | 1513.4 | 1017 | 24.8 | 2.6 | 14.4 | 11.1 | 3513 | 0 |
| 4 | Fortis Healthcare Ltd. | 952.4 | 71898 | 1105 | 623.4 | 88.8 | 8.1 | 12.1 | 9.8 | 966 | 0.1 |
| 5 | Alkem Laboratories Ltd. | 5585.5 | 66783 | 5933 | 4716.8 | 30.1 | 5.6 | 21.6 | 19.9 | 2424 | 0.9 |
| 6 | Glenmark Pharmaceuticals Ltd. | 2366.4 | 66780 | 2471 | 1356.8 | 63.8 | 7.6 | 16.2 | 12.6 | 1065 | 0.2 |
| 7 | Laurus Labs Ltd. | 1228.3 | 66311 | 1237.9 | 573.2 | 187.1 | 14.9 | 10.2 | 8.3 | 890 | 0.2 |
| 8 | Biocon Ltd. | 380.4 | 61659 | 425 | 317.9 | 43.1 | 2.2 | 7.4 | 7 | 630 | 0.1 |
| 9 | Abbott India Ltd. | 26700 | 56736 | 35921.6 | 25164 | 40.1 | 13.5 | 47.9 | 36 | 1524 | 1.5 |
| 10 | Glaxosmithkline Pharmaceuticals Ltd. | 2476.9 | 41960 | 3516 | 2218 | 45.2 | 21.3 | 67.6 | 49.4 | 1021 | 1.9 |
| 11 | Ipca Laboratories Ltd. | 1552.6 | 39390 | 1624 | 1253 | 50 | 5.7 | 15.3 | 11.9 | 948 | 0.3 |
| 12 | Aster DM Healthcare Ltd. | 742.4 | 38465 | 770 | 518.2 | 114.2 | 12.2 | 11.5 | 9.3 | 464 | 25.4 |
| 13 | Ajanta Pharma Ltd. | 3035 | 37918 | 3158.2 | 2335 | 41.2 | 10 | 32.9 | 25.1 | 1056 | 1.1 |
| 14 | Narayana Hrudayalaya Ltd. | 1820.3 | 37200 | 2371.6 | 1564.2 | 47.1 | 10.3 | 21.6 | 24.3 | 782 | 0.3 |
| 15 | JB Chemicals & Pharmaceuticals Ltd. | 2149.8 | 34517 | 2195 | 1510 | 52.3 | 10.2 | 26.7 | 21.8 | 754 | 1 |
| 16 | Global Health Ltd. | 1200.6 | 32278 | 1455.8 | 955.2 | 67.1 | 9.5 | 20.5 | 15.3 | 514 | 0 |
| 17 | Gland Pharma Ltd. | 1904.4 | 31376 | 2130 | 1385 | 44.9 | 3.4 | 12 | 7.8 | 847 | 1.1 |
| 18 | Krishna Institute of Medical Sciences Ltd | 717.6 | 28714 | 798 | 575.6 | 69.2 | 13.4 | 19 | 20.9 | 315 | 0 |
| 19 | Dr. Lal Pathlabs Ltd. | 1649.8 | 27657 | 1771.3 | 1272 | 56.2 | 13 | 31.5 | 25.2 | 510 | 1 |
| 20 | Wockhardt Ltd. | 1606.5 | 26104 | 1870 | 1086.8 | -458 | 6 | 4.1 | -1.5 | 199 | 0 |
| 21 | Piramal Pharma Ltd. | 179.8 | 23907 | 226 | 132.5 | 262.3 | 3 | 6.6 | 1.1 | -383 | 0.1 |
| 22 | Sai Life Sciences Ltd. | 1115.6 | 23653 | 1124 | 685.9 | 139 | 11 | 15.5 | 11 | 333 | 0 |
| 23 | Neuland Laboratories Ltd. | 17666 | 22665 | 19748.4 | 10598 | 87.1 | 14.9 | 23.5 | 18.5 | 179 | 0.1 |
| 24 | Pfizer Ltd. | 4818.8 | 22045 | 5987.6 | 4156.6 | 28.7 | 5.2 | 26.2 | 19.6 | 854 | 4.1 |
| 25 | Natco Pharma Ltd. | 1174.7 | 21040 | 1218 | 752.1 | 11.2 | 2.8 | 32.8 | 28 | 1545 | 0.8 |
| 26 | Onesource Specialty Pharma Ltd. | 1835.2 | 21039 | 2249.6 | 1075 | -1217.5 | 3.6 | 2.6 | -0.6 | 21 | 0 |
| 27 | Cohance Lifesciences Ltd. | 488.2 | 18677 | 1180 | 267.8 | 70.5 | 7.4 | 18.4 | 14.2 | 181 | 0 |
| 28 | Granules India Ltd. | 753 | 18658 | 761.4 | 430.6 | 37.2 | 4.9 | 16.2 | 14.5 | 595 | 0.3 |
| 29 | Syngene International Ltd. | 458.1 | 18492 | 728.4 | 380 | 37.3 | 4 | 15.4 | 11.2 | 317 | 0.2 |
| 30 | Poly Medicure Ltd. | 1652.1 | 16746 | 2638.6 | 1184 | 49.5 | 6.1 | 20.4 | 16 | 341 | 0.2 |
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
